Navigation Links
Old gastrointestinal drug slows aging, McGill researchers say
Date:1/6/2009

als are involved as clioquinol is a metal chelator," he explained. Chelation is a type of binding to metal ions and is often used to treat heavy metal poisoning.

Hekimi is optimistic but cautious when asked whether clioquinol could eventually become an anti-aging treatment.

"The drug affects a gene which when inhibited can slow down aging," he said. "The implication is that we can change the rate of aging. This might be why clioquinol is able to work on this diversity of diseases that are all age-dependent."

However, he admits to being concerned about how people may interpret his results.

"The danger is that you can buy a kilogram of this compound at a chemical wholesaler, but we don't want people to start experimenting on themselves. Clioquinol can be a very toxic substance if abused, and far more research is required."


'/>"/>

Contact: Mark Shainblum
mark.shainblum@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Chronic gastrointestinal symptoms in Korean population
2. Strategies for preventing gastrointestinal complications in severely burned patients
3. A new breakthrough in timing of urgent endoscopy for gastrointestinal bleeding patients
4. July 2008 Mayo Clinic Womens HealthSource Highlights Vitamin D, Savvy Use of Sunscreen and Gastrointestinal Upset and Celiac Disease
5. 10th World Congress on Gastrointestinal Cancer -- Barcelona, Spain
6. Protein predicts Gleevec resistance in gastrointestinal tumors
7. ASGE issues updated infection control guidelines for gastrointestinal endoscopy
8. ASGE issues updated guidelines on antibiotic prophylaxis for gastrointestinal endoscopy
9. Which segments of the gastrointestinal tract does Salmonella enteritidis penetrate?
10. The 2008 Gastrointestinal Cancers Symposium
11. Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract
Post Your Comments:
*Name:
*Comment:
*Email: